We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Welcome to the latest episode of the Full-Court Finance podcast from Zacks Investment Research where Associate Stock Strategist Ben Rains takes a look at five technology stocks that investors might want to buy for 2020, as stocks continue to climb on U.S.-China trade positivity heading into the new year.
The Dow, S&P 500, and Nasdaq all surged to new intraday highs Monday morning. This jump came after U.S. and Chinese officials announced last Friday that they reached a so-called phase one trade agreement. Wall Street and investors hope for much more down the road, but the limited agreement helps deescalate the ongoing trade fight between the world’s two largest economies.
Along with the recent U.S.-China trade truce, House Democrats announced their support for the new United States, Mexico, Canada agreement to replace NAFTA. Plus, U.S. unemployment rests at 50-year lows and corporate earnings growth is projected to return in 2020. All of these conditions set the table for what could be another strong run in 2020.
With this in mind, we dive into five tech stocks that look set to expand as part of larger growth trends within booming industries.
First, we dive into why semiconductor stocks Applied Materials (AMAT - Free Report) and Nvidia (NVDA - Free Report) appear strong, as they stand to benefit from the continued expansion of everything from cloud computing to artificial intelligence. Both chip companies have seen their shares outpace everyone from Intel (INTC - Free Report) to Micron (MU - Free Report) this year.
The episode then takes a look at cloud-focused software firms Anaplan, Inc. and Zuora, Inc. (ZUO - Free Report) . Anaplan’s growth appears impressive and it was named to Deloitte’s 2019 Technology Fast 500 list. Meanwhile, Zuora hopes to benefit from the growth of subscription-based business models.
Microsoft (MSFT - Free Report) is the most well-known firm on the list and remains one of only two public companies in the U.S. with a market cap over $1 trillion, alongside Apple (AAPL - Free Report) . MSFT’s ability to compete directly against Amazon (AMZN - Free Report) in cloud computing has helped it become one of the more stable tech plays on the market that also returns value to shareholders through buybacks and dividends.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
5 Highly-Ranked Tech Stocks to Buy for 2020
Welcome to the latest episode of the Full-Court Finance podcast from Zacks Investment Research where Associate Stock Strategist Ben Rains takes a look at five technology stocks that investors might want to buy for 2020, as stocks continue to climb on U.S.-China trade positivity heading into the new year.
The Dow, S&P 500, and Nasdaq all surged to new intraday highs Monday morning. This jump came after U.S. and Chinese officials announced last Friday that they reached a so-called phase one trade agreement. Wall Street and investors hope for much more down the road, but the limited agreement helps deescalate the ongoing trade fight between the world’s two largest economies.
Along with the recent U.S.-China trade truce, House Democrats announced their support for the new United States, Mexico, Canada agreement to replace NAFTA. Plus, U.S. unemployment rests at 50-year lows and corporate earnings growth is projected to return in 2020. All of these conditions set the table for what could be another strong run in 2020.
With this in mind, we dive into five tech stocks that look set to expand as part of larger growth trends within booming industries.
First, we dive into why semiconductor stocks Applied Materials (AMAT - Free Report) and Nvidia (NVDA - Free Report) appear strong, as they stand to benefit from the continued expansion of everything from cloud computing to artificial intelligence. Both chip companies have seen their shares outpace everyone from Intel (INTC - Free Report) to Micron (MU - Free Report) this year.
The episode then takes a look at cloud-focused software firms Anaplan, Inc. and Zuora, Inc. (ZUO - Free Report) . Anaplan’s growth appears impressive and it was named to Deloitte’s 2019 Technology Fast 500 list. Meanwhile, Zuora hopes to benefit from the growth of subscription-based business models.
Microsoft (MSFT - Free Report) is the most well-known firm on the list and remains one of only two public companies in the U.S. with a market cap over $1 trillion, alongside Apple (AAPL - Free Report) . MSFT’s ability to compete directly against Amazon (AMZN - Free Report) in cloud computing has helped it become one of the more stable tech plays on the market that also returns value to shareholders through buybacks and dividends.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>